P3 Health Partners Inc reports results for the quarter ended December 31 - Earnings Summary

• P3 Health Partners Inc PIII.OQ reported a quarterly adjusted loss of 39 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -22 cents. The mean expectation of five analysts for the quarter was for a loss of 11 cents per share. Wall Street expected results to range from -17 cents to -2 cents per share.

• Revenue rose 6.9% to $370.69 million from a year ago; analysts expected $378.06 million.

• P3 Health Partners Inc's reported EPS for the quarter was a loss of 36 cents​.

• The company reported a quarterly loss of $58.62 million.

• P3 Health Partners Inc shares had fallen by 20.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for P3 Health Partners Inc is $1.00

This summary was machine generated from LSEG data March 28 at 03:59 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)